Evidence map›Paper›PMID 16923973›Full record

ReviewJournal of vascular and interventional radiology : JVIR2006

Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations.

Riad Salem, Kenneth G Thurston

Erratum issued Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Journal of vascular and interventional radiology : JVIR, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT00906984 (A Humanitarian Device Exemption Treatment Protocol of TheraSphere® For Treatment of Unresectable Hepatocellular Carcinoma), which is not on this map. Cited by 212 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
212citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00906984 approved for marketingnot on this map

A Humanitarian Device Exemption Treatment Protocol of TheraSphere® For Treatment of Unresectable Hepatocellular Carcinoma

Typeexpanded_accessSponsorUniversity of California, IrvineConditionsHepatocellular Carcinoma, Liver Cancer, Liver Neoplasm, Primary Liver CancerArmsTheraSphere
3 · Its place in the literature

Who cites it

212 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Guideline
  4. Guideline
  5. Guideline
  6. Guideline
  7. Research reporting standards for radioembolization of hepatic malignancies.Journal of vascular and interventional radiology : JVIR · 2011
    Guideline
  8. Pooled it
  9. Radioembolization With Chemotherapy for Colorectal Liver Metastases: A Randomized, Open-Label, International, Multicenter, Phase III Trial.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021
    Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

152 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Riad SalemDepartment of Radiology, Robert H. Lurie Comprehensive Cancer, 676 North St Clair, Suite 800, Chicago, Illinois 60611, USA. r-salem@northwestern.edu
Kenneth G Thurston

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microsphere and particle technology represent the next-generation agents that have formed the basis of interventional oncology, an evolving subspecialty of interventional radiology. One of these platforms, yttrium-90 microspheres, is rapidly being adopted in the medical community as an adjunctive therapeutic tool in the management of primary and secondary liver malignancies. Given the complexity of the treatment algorithm of patients who may be candidates for this therapy and the need for clinical guidance, a comprehensive review of the methodologic and technical considerations was undertaken. This experience is based on more than 900 (90)Y infusions performed over a 5-year period.

Indexed as

BrachytherapyEmbolization, TherapeuticRadiotherapy Planning, Computer-AssistedAngiographyCarcinoma, HepatocellularDisease ManagementHumansLiver NeoplasmsMesenteryMicrospheresPatient Care TeamPatient SelectionPractice Guidelines as TopicRadiology, InterventionalRadiopharmaceuticalsRadiotherapy DosageRadiopharmaceuticalsYttrium Radioisotopes

Identifiers

PMID16923973

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.